Supar Health ApS: Financial statements 2023
CVR: 41298790
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Supar Health ApS (CVR 41298790) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK 680. The solvency ratio was 2%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 680
- Total Assets
- DKK 34,768
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Supar Health ApS has published its annual report for 2022. The net result was DKK 0.
About Supar Health ApS
Supar Health ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Aetas ApS. The management consists of Thomas Gielsgaard Hargreave. The company is owned by Aetas Healthcare ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -332,648 and a net result of DKK -332,474 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -297,658.
